We’re tracking in-house compensation. Take the Law360 Survey
Click here
Finch Therapeutics Group, Inc.
-
July 24, 2026
A Delaware bankruptcy judge on Friday conditionally approved the disclosure statement for microbiome treatment developer Finch Therapeutics' Chapter 11 plan, allowing it to solicit creditor votes.
-
July 08, 2026
Microbiome treatment developer Finch Therapeutics will ask a Delaware bankruptcy judge to approve a Chapter 11 plan that would allow it to sell all assets to a rival company and exit bankruptcy. Here's a look at the liquidating plan it is hoping to get confirmed.
-
March 25, 2026
A team of attorneys from Chipman Brown Cicero & Cole LLP and Ropes & Gray LLP is steering the Chapter 11 case of Finch Therapeutics, a company that develops treatments to improve the health of the body's microbiome.
-
March 25, 2026
Microbiome treatment developer Finch Therapeutics told a Delaware bankruptcy judge Wednesday that its lack of income or ability to collect on a patent judgment justified its Chapter 11 filing despite a lack of secured debts.
-
March 24, 2026
The maker of spandex is looking to swap its debt for equity in Chapter 11, a longtime book distributor plans to finish winding down operations while its bankruptcy keeps an automatic stay on litigation, and a microbiome treatment developer wants to sell its assets in bankruptcy.
-
March 23, 2026
A company that develops treatments to improve the health of the body's microbiome sought Chapter 11 protection, saying it had never generated a positive cash flow and faces unresolved litigation and a burdensome lease.